Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $48,395 | $13,288 | -$7,642 | -$10,189 |
| Dep. & Amort. | $31 | $30 | $30 | $31 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $9,843 | -$2,659 | -$1,574 | $27 |
| Other Non-Cash | -$60,256 | -$14,228 | $5,667 | $8,196 |
| Operating Cash Flow | -$1,987 | -$3,569 | -$3,519 | -$1,935 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$4 | -$3 | -$11 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$5,239 | -$62,718 | -$8,444 | -$12,164 |
| Inv. Sales/Matur. | $44,346 | $9,677 | $32,063 | $28,004 |
| Other Inv. Act. | -$267 | -$1,958 | $0 | -$65 |
| Investing Cash Flow | $38,840 | -$55,004 | $23,616 | $15,764 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$187 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$393 | -$373 | $0 | -$1,198 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$2 |
| Financing Cash Flow | -$393 | -$373 | $0 | -$1,387 |
| Forex Effect | -$78 | $226 | -$1 | -$126 |
| Net Chg. in Cash | $36,382 | -$58,719 | $20,096 | $12,316 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,797 | $74,516 | $54,420 | $42,104 |
| End Cash | $52,179 | $15,797 | $74,516 | $54,420 |
| Free Cash Flow | -$1,987 | -$3,573 | -$3,522 | -$1,946 |